Objective: The T allele of the single-nucleotide polymorphism rs7903146 in TCF7L2 (transcription factor 7 like 2 gene) is associated with type 2 diabetes mellitus. The aim of this study was to analyze whether there is an allele-dosage effect on changes of insulin resistance and sensitivity indices in overweight children participating in a lifestyle intervention. Methods: We genotyped rs7903146 in 236 overweight children (mean age 10.7 years, mean body mass index (BMI) 28.1 kg/m 2 ) completing a 1-year lifestyle intervention. Degree of overweight as BMI-SDS, homeostasis model assessment for insulin resistance (HOMA-IR) and the insulin sensitivity index QUICKI were measured before and after intervention. Results: Lifestyle intervention resulted in an overweight reduction of À0.29 ± 0.02 BMI-SDS. HOMA-IR (À0.63 ± 0.22) and QUICKI ( þ 0.008 ± 0.003) indices improved significantly (Po0.05) in the course of the intervention in the 155 children with a decrease of BMI-SDS. There was an additive negative effect of T allele on changes of HOMA-IR (P ¼ 0.041) and QUICKI (P ¼ 0.001) in linear regression analyses adjusted to changes of weight status, age, gender and pubertal stage. Conclusions: Overweight children showed a negative dosage-allele effect per T allele at single-nucleotide polymorphism rs7903146 in TCF7L2 concerning an improvement of insulin resistance and sensitivity after overweight reduction in a lifestyle intervention. This finding further suggests that this polymorphism might be involved in glucose metabolism.
Introduction
Reduction of overweight improves glucose metabolism in overweight children. 1 However, not all children reducing overweight demonstrated an improvement of glucose metabolism, 2 suggesting further influencing factors such as genetic markers. Variations in TCF7L2 (transcription factor 7 like 2 gene) might contribute to insulin sensitivity and resistance. TCF7L2 encodes a transcription factor and hereby regulates blood glucose homeostasis through the regulation of proglucagon gene expression. 3 The single-nucleotide polymorphism rs7903146 in TCF7L2 is associated with an increased risk of type 2 diabetes mellitus. [3] [4] [5] [6] Variants in TCF7L2 influence both insulin secretion and resistance. 4, 7 Therefore, the primary aim of this study was to investigate whether there is an allele-dosage effect of the T allele of rs7903146 in TCF7L2 on changes of insulin resistance and sensitivity in children enrolled in a lifestyle intervention.
Patients and methods
The ethics committees of the Universities of Witten/ Herdecke and Duisburg-Essen approved this study. Written informed consent was obtained from all subjects and their parents.
We examined 236 unrelated overweight children aged 6-16 years (mean age 10.7 ± 1.7 years, 45% male; mean body mass index (BMI) 28.1 ± 0.3 kg/m 2 ) completing the 1-year intervention 'Obeldicks'. None of the children were on any medication or suffered from endocrine disorders including type 2 diabetes mellitus. Overweight was defined by a BMI490 th percentile for
German children according to the International Task Force. 8, 9 We used the LMS method to calculate BMI-SDS as a measure of the degree of overweight.
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The intervention 'Obeldicks' has been described elsewhere in detail. 11 Briefly, this outpatient intervention program was based on physical exercise, nutrition education and behavior therapy including individual psychological care of the child and his/her family. The pubertal stage was determined according to Marshall and Tanner by one well-trained physician. The pubertal developmental stage was categorized into two groups (prepubertal/pubertal).
Fasting serum glucose and insulin were measured before and after the 1-year intervention using commercially available test kits (Roche Diagnostics, Mannheim, Germany; Abbott, Wiesbaden, Germany). Intra-and interassay variations of these variables were o5%. Homeostasis model assessment for insulin resistance (HOMA-IR) and HOMA-B% index as an approximation of insulin secretion were calculated:
)À3.5). In addition, the quantitative insulin sensitivity check index was calculated:
The single-nucleotide polymorphism rs7903146 was genotyped using tetra-ARMS PCR 14 as described earlier. 15 Positive controls for the variant alleles were run on each gel. For validity of the genotypes, allele determinations were rated independently by at least two experienced individuals.
Statistics
Statistical analysis was performed using the statistical software package Winstat for Exel. All variables were normally distributed except HOMA-B%. Therefore, HOMA-B% values were log-transformed for all statistical comparisons. Relationships between the ordinal-coded genotypes and baseline weight status, glucose, insulin, HOMA-IR, HOMA-B% and QUICKI were exploratively analyzed by linear regression models under an allele-dosage model. The obtained effect estimates were adjusted for gender, age, stage of puberty and weight status (BMI-SDS). According to an additive model, the allele-dosage effect of the risk T allele was assessed by linear regression adjusted for gender, age, pubertal stage, baseline insulin, baseline glucose and reduction of BMI-SDS. Agreement between change of BMI-SDS and change of HOMA-IR, HOMA-B% or QUICKI was estimated by Pearson correlation coefficients. All reported P-values were two-sided. A P-value o0.05 was considered as statistically significant. Data were presented as mean and standard error (s.e.).
Results
Eighteen (8%) children were homozygous for the T allele of rs7903146, 97 (41%) were heterozygous and 121 (51%) were homozygous carriers of the wild-type (C) allele. Table 2 ). The estimated effect adjusted for age, gender, pubertal stage and change of BMI-SDS was þ 0.68±0.01 for HOMA-IR per additional T allele and À0.010±0.004 for QUICKI per additional T allele. The variance explained by these models was only 6.5% for HOMA-IR and 6.8% for QUICKI. Median and interquartile range as variable not normally distributed; none of these associations were significant (P-values derived from linear regression analyses under allele-dosage model adjusted for gender, age, stage of puberty and weight status (BMI-SDS); HOMA-B% were log-transformed for statistical comparison).
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The children with different genotypes did not differ in frequency of onset of puberty (TT:8%; TC:16%; CC:14%; Fisher's exact test: P ¼ 0.785) or gender (P ¼ 0.248). HOMA-IR, HOMA-B%, QUICKI, insulin and glucose concentrations did not differ significantly between girls and boys.
Discussion
This is the first study pertaining to the polymorphism rs7903146 in TCF7L2 and changes of insulin resistance and sensitivity indices in overweight children participating in lifestyle interventions. The achieved overweight reduction and improvement of HOMA-IR and QUICKI in our intervention program were comparable to those in the previous reports. 1, 11, 16 Interestingly, we found only a weak correlation between change of weight status and changes of the HOMA-IR, QUICKI and HOMA-B%, suggesting further influence factors for example, different genetic backgrounds. The T allele at rs7903146 was associated with a significant negative dosage effect per allele on the improvement of HOMA-IR and QUICKI after the lifestyle intervention independently of gender. These findings support an impact of this polymorphism on glucose metabolism in overweight children participating in a lifestyle intervention.
We hypothesize that the TCF7L2 gene variants influence the b-cell capacity. In our study, the effect of rs7903146 on changes of QUICKI and HOMA-B% was stronger than the effect on changes of HOMA-IR. The T allele was associated with a significant lower improvement of insulin secretion after lifestyle intervention (see Table 2 ). This finding is in line with the study of Florez et al. 7 demonstrating in a longitudinal study that the T allele at rs7903146 is associated with impaired b-cell function. A decreased insulin secretion for homozygotes of the T allele at rs7903146 was described after glucose stimulation in adults with diabetes. 7 In contrast to this theory, a tendency of higher HOMA-B% values was observed in carriers of the T allele at rs7903146 in a previous study of our research group. 15 However, after adjustment for potential confounders on glucose metabolism such as pubertal stage, age and gender, this difference was not significant any more. In conclusion, further experimental and longitudinal studies are necessary to clarify the role of the TCF7L2 gene variants in the progression to type 2 diabetes in humans. In contrast to this experimental analysis and larger crosssectional studies in adults, 4, 7 but in concordance with four smaller previous cross-sectional studies in children 15, 17 and adults, 18, 19 we did not find an association of variations in TCF7L2 with HOMA-IR or QUICKI at baseline. This discrepancy may be explained by the fact that individuals in medium-sized study groups with too low power were analyzed in these cross-sectional analyses, who are also susceptible to many confounders such as influence of physical activity, smoking and diet on glucose metabolism. Furthermore, these different findings may be caused by different age ranges as some gene effects may not occur until adulthood. Our study has some further potential limitations. It is possible that an interaction between TCF7L2 and environmental factors such as diet and physical activity may influence the change of glucose metabolism. We measured glucose and insulin only in the fasting state. HOMA-IR, HOMA-B% and QUICKI are only assessments of insulin resistance and sensitivity. 20 To evaluate insulin secretion, stimulated values after glucose would have been very helpful. Clamp studies are the gold standard for analyzing insulin resistance and sensitivity but are very difficult to perform longitudinally in large samples of children. Finally, we tested only rs7903146 at TCF7L2. It seems unlikely but we cannot rule out that analyzing other polymorphisms of this gene would have shown significant associations with changes of glucose metabolism parameters. With regard to validity of this finding, the small effect size and the moderate size of the study group, subsequent replication studies are indispensable. We retrospectively had 79% power to detect the observed difference of 0.2 U in HOMA-IR given an a error of 0.05, the study sample of 236 children with Median and interquartile range as variable not normally distributed; P-values derived from linear regression analyses under allele-dosage model adjusted for gender, age, pubertal stage, baseline insulin and glucose levels, as well as change of weight status (BMI-SDS) except for change of BMI-SDS; change of HOMA-B% was included as log of HOMA-B% 1-year follow-up -log of HOMA-B% baseline in the linear regression analysis.
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In summary, we found a negative allele-dosage effect of the T allele of rs7903146 in the TCF7L2 gene on the changes in the HOMA-IR, the insulin sensitivity check index QUICKI and insulin secretion index HOMA-B% in children reducing their overweight in a lifestyle intervention. These findings suggest an impact of this polymorphism on glucose metabolism in overweight children.
